Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141567 · ClinicalTrials.gov registry record
LYmphangiogenesis FacTors in Heart Failure States
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 100
- Enrollment target
NCT03141567: Completed study, sponsored by Medical University of South Carolina.
NCT03141567 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03141567 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
Heart failure often causes fluid to accumulate in the body, leading to congestion and swelling. However, some people who have had heart failure for a long time seem to have very little congestion or swelling, even when the heart failure is poorly treated. The investigators think that this is because lymphatic vessels are able to grow and remove fluid to prevent congestion. The investigators do not know how lymphatic vessels grow. This study will investigate the blood levels of various proteins to try to figure out how the lymph vessels of people with long-standing heart failure might grow.
Primary Outcome
VEGF levels in systemic venous, pulmonary arterial, and pulmonary venous samples in participants with left heart failure versus those without left heart failure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-05-18 |
| Est. Completion | 2023-01-24 |
What the finished NCT03141567 record still lists
NCT03141567 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03141567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03141567 about?
NCT03141567 is a clinical study titled "LYmphangiogenesis FacTors in Heart Failure States". Heart failure often causes fluid to accumulate in the body, leading to congestion and swelling. However, some people who have had heart failure for a long time seem to have very little congestion or swelling, even when the heart failure is poorly treated. The investigators think that this is because...
What is the current status of trial NCT03141567?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-05-18. Estimated completion is 2023-01-24.
Who is sponsoring clinical trial NCT03141567?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI